Britannia Life Sciences Inc. (CSE:BLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.100
+0.005 (5.26%)
At close: Feb 27, 2026
42.86%
Market Cap 16.23M
Revenue (ttm) 260.58K
Net Income (ttm) 8.22M
Shares Out 162.25M
EPS (ttm) 0.05
PE Ratio 1.97
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,745
Average Volume 171,226
Open 0.100
Previous Close 0.095
Day's Range 0.100 - 0.100
52-Week Range 0.050 - 0.140
Beta -0.12
RSI 59.31
Earnings Date Feb 27, 2026

About Britannia Life Sciences

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Peter Shippen
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol BLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.